Lyme disease: recommendations for diagnosis and treatment.
about
Lyme carditis: a United Kingdom perspectiveImmunoblot interpretation criteria for serodiagnosis of early Lyme diseaseLyme disease: a search for a causative agent in ticks in south-eastern AustraliaBorrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosisBorrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 casesEarly and specific antibody response to OspA in Lyme DiseaseRational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment.Lyme disease in Taiwan: first human patient with characteristic erythema chronicum migrans skin lesion.Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skinBorrelia burgdorferi bind to epithelial cell proteoglycans.Physician beliefs, attitudes, and approaches toward Lyme disease in an endemic area.Antibiotic therapy for Lyme disease in MarylandLyme disease: a growing threat to urban populationsDetection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosisDecreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis.Infectious diseases and AIDSLyme disease in paediatricsIn vitro activity of vancomycin against the spirochete Borrelia burgdorferi.Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.Lyme Disease: Review from a Canadian perspective.Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and P39 protein in patients with PCR- or culture-proven late Lyme borreliosis.New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocolLyme disease. A Canadian perspectiveThe polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids.Lyme disease in the United KingdomSeroprevalence of Borrelia burgdorferi in North Eastern India.In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.Skin manifestations of lyme borreliosis: diagnosis and management.Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis.Improved serodiagnosis of Lyme diseaseUtilization of tests for Lyme disease antibody at a university hospital.In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes.Acrodermatitis chronica atrophicans: a case report and review of the literature.Late Lyme borreliosis: epidemiology, diagnosis and clinical features.Treatment of Lyme arthritis.Antibodies against some bacterial antigens in children.Isolation of Borrelia burgdorferi from ticks in southern CaliforniaIn vitro susceptibility of isolates of Borrelia burgdorferi s.l. to antimicrobial agents.
P2860
Q22242033-AE871E8C-5497-41C4-B860-051BD05D8B5CQ24646591-808670A3-B9D9-4553-8BC8-49B14E6F1E22Q27485604-B0D63510-143B-4462-A582-FEDEA0E29421Q28141853-C3155CA9-E756-4CA3-9415-4522C6803591Q28297049-11C48BB8-BBAF-4745-94A7-C1883BA0E343Q33367218-0433DD86-55BD-43D5-86B6-F583232975CBQ33565345-F90CCAA5-BCC6-407D-BBCA-3B3FD55F61BDQ33660064-A2E9D437-18DF-44FA-9937-8761B2C7ADEAQ33754842-297E4E24-F04D-4EC8-B26C-5152F5A123B0Q33981545-04CF15C3-025D-45AD-829D-756979E860ABQ34127449-74B09B5E-8EA6-46DE-B5E9-31E89D5915D7Q34341882-C9FADB2D-1723-478D-8B05-F17033FFB573Q34454246-2F9B6A73-0259-4E60-8DF2-6F5456407AFFQ35110893-0B7F8D0A-4F66-44AE-A147-550CF04FA2A6Q35319553-904166B0-0150-4E2F-9700-B408A72F986BQ35516914-8956418E-2402-4659-9CFC-03975279CC29Q35531014-44B31DD6-F9E7-47CE-AE82-C11644AAB3C1Q35627026-E1DB5680-B9D0-4B00-9732-B6C0D680588CQ35815090-64D54BFF-B6F8-4CF9-A841-E3C4F02A49C3Q35818085-1C53CE42-31A2-4BA1-97A5-F6C950F9BD77Q36284504-76FC5B13-90FC-479A-81CE-4FB05D97B951Q36524148-8BF1B337-E0D8-4DC2-B6DB-AA2E4B072F1CQ36539038-8EA1FC91-BBED-4DE1-A320-064CA9F9A89BQ36652612-FDCE94B2-2B3A-4B88-BB00-3192A852BABFQ36782448-B7EBCEAC-01C0-4808-9305-5D51B6401F4CQ36902199-31D35547-572E-4C0A-83D3-7730A5B20F55Q37039658-DB114D1E-79C0-4655-B2AE-2176DA4D6916Q37248535-1D3FF367-7680-4196-969B-67FC7DC3ACD9Q37313420-3480BB2F-5533-48FD-AE58-D70EACE71E40Q39457407-FDF6C8CC-D32E-45E5-A686-ACE92F50A29DQ39754935-7D602AC0-1D84-4871-AB65-ED2E8FFA9749Q39810467-D8F2ED90-1708-421B-B8BF-338FCA1C59DAQ39866294-0F346A41-B0D0-48F0-AF79-645DAA1ED2D2Q40152268-06EF3EFF-0D07-4B01-A27D-A84D6A193AB3Q40654615-699A6A03-C104-4FF3-B059-EE00BA0EAB22Q41072359-7DC9CC5C-B71B-4FFC-8DB3-5127C5054A47Q41148107-1E21B852-EE81-481B-8A08-E103E03FA458Q41497802-74B3DFD6-BC88-4670-93EA-645AB33B41D0Q41507170-8AA542B9-FB21-47AA-B253-63B3C9EF64E8Q43604354-1D753763-EF29-4E5D-9BB2-1BE0A0034D81
P2860
Lyme disease: recommendations for diagnosis and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lyme disease: recommendations for diagnosis and treatment.
@en
Lyme disease: recommendations for diagnosis and treatment.
@nl
type
label
Lyme disease: recommendations for diagnosis and treatment.
@en
Lyme disease: recommendations for diagnosis and treatment.
@nl
prefLabel
Lyme disease: recommendations for diagnosis and treatment.
@en
Lyme disease: recommendations for diagnosis and treatment.
@nl
P1476
Lyme disease: recommendations for diagnosis and treatment.
@en
P2093
P304
P356
10.7326/0003-4819-114-6-472
P407
P577
1991-03-01T00:00:00Z